Paul K. Audhya, CHIEF MEDICAL OFFICER at KalVista Pharmaceuticals, Inc. (KALV), sold 2,686 shares at $20.22 ($54K) on 2026-04-17, disclosed to the SEC on 2026-04-20.
Open-market sale of $54k KALV by CHIEF MEDICAL OFFICER. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| KALV | SELL | 2026-05-19 | $28K | — | Filing → |
| KALV | SELL | 2026-02-24 | $167K | — | Filing → |
| KALV | SELL | 2026-02-19 | $17K | — | Filing → |